Survival Outcome and Predictors of Survival in Elderly Breast Cancer Patients following Curative Treatment [0.03%]
老年乳腺癌患者接受根治治疗后的生存结果和生存预测因素
Anoop T M,Rona Joseph P,Rajeev K R et al.
Anoop T M et al.
Anoop TMObjectives The lack of data on management of elderly breast cancer patients' population makes most oncologists reluctant to treat them with the standard treatment protocols as advised for the younger patients. This study was done to...
Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India [0.03%]
雌激素受体和孕激素受体阴性乳腺癌中的雄激素受体表达-来自印度北部一家三级医院的研究
Sumeet Sidhu,Kanwardeep Singh Kwatra,Pamela Alice Kinsley
Sumeet Sidhu
Sumeet SidhuObjectives Breast cancer is the leading cause of cancer-related deaths in women. Estrogen (ER) and progesterone receptor (PR) status and Her2 overexpression are major determinants in therapeutic decision making. Triple-negative ...
Clinical, Radiological and Histological Features and Their Association with Extranodal Extension in Buccoalveolar Complex Squamous Cell Carcinoma [0.03%]
口腔复合鳞状细胞癌的临床、影像及组织病理特征与窦外侵犯的关系
Ronald Anto,Jeyashanth Riju,Praveen Chinniah et al.
Ronald Anto et al.
Jeyashanth RijuObjectives The study was aimed to (1) evaluate the effectiveness of clinical examination, intraoperative finding, and contrast-enhanced computed tomography (CECT) to detect extranodal extension (ENE) in buccoalveolar complex ...
BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India [0.03%]
BRAF V600E突变及其他：来自印度三级癌症转诊中心的黑色素瘤分子视角
Vaibhavi Vengurlekar,Omshree Shetty,Mamta Gurav et al.
Vaibhavi Vengurlekar et al.
Vaibhavi VengurlekarObjectives Malignant melanoma demonstrates frequently occurring mutations of genes in the serine/threonine kinase pathway, namely BRAF, NRAS, and neurofibromin 1. There is rare documentation of a detailed analysis of the...
Chemotherapy-Induced Alopecia: Can We Measure the Level of Distress in Oncology Patients? (The ALDO Study) [0.03%]
化疗引起的脱发：我们能测量肿瘤患者的压力水平吗？（ALDO研究）
Prathepa Jagadish,Vidya Rane,Prabhat Bhargava et al.
Prathepa Jagadish et al.
Prathepa JagadishChemotherapy-induced alopecia (CIA) has a strong and definite negative impact on body image in terms of perception of aging, depression, loss of interest, and confidence. This study involved the translation and validation o...
Critical Analysis of Advanced High-Grade Serous Epithelial Ovarian Cancer in Women: An Experience of 100 Cases from a Regional Cancer Center in Northeast India [0.03%]
东北印度地区癌症中心100例个案经验：女性高级别浆液性上皮卵巢癌的批判分析
Debabrata Barmon,Sharda Patra,Megha Nandwani et al.
Debabrata Barmon et al.
Debabrata BarmonOvarian cancer is the sixth most common cancer in women worldwide. Patients with ovarian carcinoma mostly present at an advanced stage with serous type of epithelial ovarian cancers, which is the most lethal of all pelvic ma...
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario [0.03%]
辅助治疗中的曲妥珠单抗心脏毒性：真实世界案例分析
Sarita Shrivastva,Stalin Chowdary Bala,Rachana Chennamaneni et al.
Sarita Shrivastva et al.
Rachana Chennamaneni Trastuzumab, a humanized monoclonal antibody, significantly improves outcomes in HER 2-neu positive breast cancer. The incidence of cardiotoxicity with trastuzumab is approximately 8 to 10%. This study was designed to a...
Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience [0.03%]
急性早幼粒细胞白血病诱导化疗并发症的机构经验
Rajani Priya Yedla,Stalin Chowdary Bala,Venkateswara Rao Pydi et al.
Rajani Priya Yedla et al.
Stalin Chowdary BalaIntroduction Acute promyelocytic leukemia (APL) has transformed from a highly fatal disease to a highly curable one. Induction deaths continue to represent one of the major impediments in modern therapy of APL. Sepsis, h...
Facilitators and Challenges in Patient's Satisfaction with Quality of Cervical Cancer Care in a Tertiary Care Hospital, Puducherry, India: A Qualitative Study [0.03%]
印度浦那三级医疗保健医院接受宫颈癌治疗患者对护理质量满意度的影响因素及面临的挑战——一项质性研究
Shikha Yadav,Venkatachalam Jayaseelan,Jagadesan Pandjatcharam et al.
Shikha Yadav et al.
Shikha YadavBackground Chronic diseases require more attention in terms of patient satisfaction due to their physically and mentally exhausting nature. Cancer burden in India for 2021 was 26.7 million disability-adjusted life years (DALYs),...
Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols [0.03%]
一项关于剂量密集型乳腺癌治疗方案中新辅助/辅助用药3毫克培格尔粒细胞集落刺激因子的给药时间和疗效的Ⅰ/Ⅱ期研究
Amol Patel,Abhishek Pathak,Arti Sarin et al.
Amol Patel et al.
Amol PatelBackground Peg-GCSF has similar efficacy at a dose of 60 µg/kg and 100 µg/kg. The conventional 6 mg SC dose was based on the maximum tolerable dose. In Japan, 3.6 mg dose was approved on the basis of dose finding studies. Peg-GC...